Your gift is 100% tax deductible
Español
PDFs by language
Our 24/7 cancer helpline provides information and answers for people dealing with cancer. We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear.
Live Chat available weekdays, 7:00 am - 6:30 pm CT
Call us at 1-800-227-2345
Available any time of day or night
Our highly trained specialists are available 24/7 via phone and on weekdays can assist through online chat. We connect patients, caregivers, and family members with essential services and resources at every step of their cancer journey. Ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include:
For medical questions, we encourage you to review our information with your doctor.
Every donation counts.
Your gift helps fund crucial, lifesaving research and support for
those facing breast cancer.
The amount must be greater than or equal to $5
Your gift is 100% tax deductible
Treating Hodgkin lymphoma in children is slightly different than treating it in adults.
For both children and adults, the main goal of treatment is to cure the lymphoma without causing long-term problems. But doctors adjust treatment based on a child’s age, the extent of their lymphoma, how well the lymphoma is responding to treatment, and other factors.
If radiation therapy is used, the dose and area treated are kept as small as possible. If a girl or young woman needs radiation on the lower part of her body, her ovaries should be protected to help preserve her fertility.
Children’s bodies tend to tolerate chemotherapy better in the short term than adults. But some side effects are more likely to happen in children. Some of these side effects could be long-term or might not happen until years later, so children who survive cancer need careful attention for the rest of their lives.
For children with classic Hodgkin lymphoma (cHL), chemo is typically the main treatment. Low doses of radiation might also be part of treatment, but doctors try to avoid giving it to children when possible.
The chemo regimens used for children often include combinations of more drugs than are used in adults. This is especially true for lymphomas that have unfavorable features or are more advanced.
In some situations, an immunotherapy drug such as brentuximab vedotin (Adcetris) or nivolumab (Opdivo) might be included as well.
This approach has had excellent success rates, even for children with more advanced disease.
Chemo: Treatment generally starts with chemo alone. PET scans may be done to see if treatment is working and/or if there's any lymphoma left in the body.
If the Hodgkin lymphoma doesn’t go away completely: Radiation therapy or more chemo might be needed.
Radiation therapy if necessary: Studies suggest that Hodgkin lymphoma in children can be cured without radiation. This avoids the long-term problems it can cause. If radiation therapy is used, the dose and area treated are kept as small as possible.
Treatment likely involves a more intense chemo regimen. In some cases, it includes the immunotherapy drug brentuximab vedotin.
Radiation therapy is likely given as well, but the dose and field of radiation are kept as small as possible.
Treatment for these more advanced lymphomas typically begins with more intense chemo. It might include an immunotherapy drug such as brentuximab vedotin or nivolumab.
Radiation therapy might be given to areas with bulky disease (areas that contain a lot of lymphoma).
If the lymphoma comes back or is no longer responding to treatment, different types of chemo regimens might be tried.
Other options might include a stem cell transplant or treatment with an immunotherapy drug, sometimes along with chemo.
Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is very rare in children. There's no single best treatment, and treatments used are often much like those used to treat cHL in children and/or to treat adult NLPHL.
There is one exception. In the early stages of NLPHL in children, surgery to remove the affected lymph node may be the only treatment needed. After surgery, the child is watched closely for signs of lymphoma. Chemo can be used if it comes back.
Since the 1960s, most children and teens with cancer have been treated at special centers designed for them. Since then, we have learned more about treating childhood cancer, and it has become even more important for children to be treated by experts in this area.
Most children in the United States are treated at a center that is a member of the Children’s Oncology Group (COG). All of these centers are associated with a university or children’s hospital.
These centers offer the advantage of having a team of specialists who are experienced with the differences between adult and childhood cancers, as well as the unique needs of children and their families.
In these centers, doctors treating children with Hodgkin lymphoma often use treatment that is part of a clinical trial. The purpose of these studies is to find the best treatments that cause the fewest side effects.
You can learn more about this in How to Find the Best Cancer Treatment for Your Child.
This team usually includes pediatric oncologists, surgeons, radiation oncologists, pathologists, pediatric oncology nurses, and nurse practitioners.
Childhood cancer centers also have psychologists, social workers, child life specialists, nutritionists, rehabilitation and physical therapists, and educators who can support your entire family.
Any time a child or teen is diagnosed with cancer, it affects every family member and nearly every aspect of the family’s life. You can read more about coping with these changes in Childhood Cancer.
Developed by the American Cancer Society medical and editorial content team with medical review and contribution by the American Society of Clinical Oncology (ASCO).
Castellino SM, Pei Q, Parsons SK, et al. Brentuximab vedotin with chemotherapy in pediatric high-risk Hodgkin's lymphoma. N Engl J Med 2022;387:1649-1660.
Herrera AF, LeBlanc M, Castellino SM, et al. Nivolumab+AVD in advanced-stage classic Hodgkin's lymphoma. N Engl J Med 2024;391:1379-1389.
Metzger ML, Link MP, Billett AL, et al. Excellent outcome for pediatric patients with high-risk Hodgkin lymphoma treated with brentuximab vedotin and risk-adapted residual node radiation. J Clin Oncol 2021;39:2276-2283.
Harker-Murray P, Mauz-Korholz C, Leblanc T, et al. Nivolumab and brentuximab vedotin with or without bendamustine for R/R Hodgkin lymphoma in children, adolescents, and young adults. Blood 2023;141:2075-2084.
Marr K, Ronsley R, Nadel H, et al. Ifosfamide, gemcitabine, and vinorelbine is an effective salvage regimen with excellent stem cell mobilization in relapsed or refractory pediatric Hodgkin lymphoma. Pediatr Blood Cancer 2020;67:e28167.
National Cancer Institute. Childhood Hodgkin Lymphoma Treatment (PDQ®)–Health Professional Version. April 16, 2025. Accessed at www.cancer.gov/types/lymphoma/hp/child-hodgkin-treatment-pdq on July 20, 2025.
National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines): Pediatric Hodgkin Lymphoma. Version 2.2025. Accessed at www.nccn.org/professionals/physician_gls/pdf/ped_hodgkin.pdf on July 20, 2025.
Last Revised: October 6, 2025
American Cancer Society medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.
Sign up to stay up-to-date with news, valuable information, and ways to get involved with the American Cancer Society.